Skip to main content

Table 2 Multiple logistic regression analysis of clinical and pathological factors that can be predictors of lymph node metastasis (pN0/pN1, 0/1) in the patients with PTMC. Results were also confirmed by chi-square test

From: Which papillary thyroid microcarcinoma should be treated as “true cancer” and which as “precancer”?

Variables

Patients with pN0 (n = 115)

Patients with pN1 (n = 62)

P value (χ2 test)

Logistic regression analysis

OR

± 95% CI

P value (Wald test)

N (%)

N (%)

Gender

 

0.065

0.93

0.42–2.06

0.858

 Male

11 (9.6)

12 (19.3)

 

 Female

104 (90.4)

50 (80.7)

 

Age

  

0.303

0.96

0.51–1.80

0.890

 < 55 years

74 (64.4)

35 (56.5)

 

 ≥ 55 years

41 (35.6)

27 (43.5)

 

Diagnosed as multifocal

  

< 0.0001*

9.40

4.6–19.3

< 0.0001*

 No

94 (81.7)

20 (32.3)

 

 Yes

21 (18.3)

42 (67.7)

 

Diagnosed as bilateral

 

< 0.0001*

2.90

0.0–12.8

< 0.0001*

 No

115 (100.0)

47 (75.8)

 

 Yes

0 (0.0)

15 (24.2)

 

Tumor size

 

< 0.0001*

65.80

15.1–287.3

< 0.0001*

 < 0.5 cm

79 (68.7)

2 (3.2)

 

 ≥ 0.5 cm

36 (31.3)

60 (96.8)

 

Capsular invasion

 

0.047

2.54

0.98–6.56

0.052

 No

106 (92.2)

51 (82.3)

 

 Yes

9 (7.8)

11 (17.7)

 
  1. PTMC papillary thyroid microcarcinoma, CI coefficient interval, *statistically significant